2篇
您的检索式：作者名="Lance ERodewald"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus—Sichuan Province,China,2019显示文摘What is already known about this topic?After the type 2 strain of the live,attenuated poliovirus vaccine was withdrawn globally in 2016,any identification of a type 2 poliovirus is a Public Health Emergency of International Concern.A vaccinederived type 2 poliovirus(VDPV2)was identified in Sichuan,prompting an urgent,comprehensive investigation and response.What is added by this report?Type 2 monovalent,live,attenuated oral poliovirus vaccine(mOPV2)is being used to respond to the numerous VDPV2 outbreaks seen around the world.In contrast,the response in Sichuan used Sabin strain inactivated poliovirus(sIPV)to stop circulation of the VDPV2.In the 6 months following the vaccination response,there have been no VDPV2s detected in Sichuan,despite extensive search.What are the implications for public health practices?Further search for the VDPV2 must continue in order to determine whether transmission has been stopped.The ongoing investigation and response to the Sichuan VDPV2 is providing evidence to the Global Polio Eradication Initiative on managing VDPV2 outbreaks. | Jiushun Zhou Ning Wen Yong Zhang Qi Qi Chunxiang Fan Dongmei Yan Xiaoping Zhu Lixin Hao Shuangli Zhu Yu Liu Xiaozhen Ma Chao Ma Lei Nan Yong Chen Qianli Ma Cheng Wang Kun Deng Lei Cao Ge Shao Xianxiang Ding Hong Yang Zhijie An Lance ERodewald Aiqiang Xu Huaqing Wang Zijian Feng Zundong Yin Xianping Wu Wenbo Xu | 2020 | China CDC weekly2020，2，11： | 3 |
| 2 | Effectiveness of DTaP Against Pertussis in≤2-Year-Old Children—Linyi Prefecture,Shandong Province,China,2017–2019显示文摘Summary What is already known about this topic?Vaccine effectiveness(VE)is positively correlated with the number of administered co-purified diphtheria,tetanus,and acellular pertussis vaccine(DTaP)doses.A matched case-control study conducted in Zhongshan City revealed that the co-purified DTaP VE against pertussis-related illnesses in children aged 4–11 months was 42%for one dose,88%for two doses,and 95%for three doses,respectively.What is added by this report?The results of this study contribute to the current body of research.We found that the VE of co-purified DTaP against pertussis-related illness and hospitalization increased substantially,ranging from 24%–26%after one dose to 86%–87%after four doses. | Pinpin Zhu Dan Wu Yan Wang Xiaoxue Liu Lance ERodewald Yixing Li Hui Zheng Lei Cao Yifan Song Li Song Xiaodong Zhao Jianyi Yao Fuzhen Wang Mingshuang Li Qian Zhang Tingting Yan Zundong Yin | 2023 | China CDC weekly2023，5，17： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员